Congleton, United Kingdom

Brian R Holloway

This inventor holds 10 USPTO granted patents. Top assignees: Imperial Chemical Industries Limited, Zeneca Limited. Active years: 1988-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian R Holloway. Retrieved from https://idiyas.com/inventor/brian-r-holloway

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 211(Granted Patents)


Location History:

  • Cheshire, GB (1993)
  • Congleton, GB (1988 - 1996)

Company Filing History:


Years Active: 1988-1996

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Brian R Holloway: Innovator in Chemical Compounds

Introduction

Brian R Holloway is a notable inventor based in Congleton, GB. He has made significant contributions to the field of chemical compounds, holding a total of 10 patents. His work primarily focuses on compounds that serve therapeutic purposes, particularly in the areas of anti-obesity and hypoglycaemic treatments.

Latest Patents

Holloway's latest patents include innovative chemical compounds described as β3-adrenoceptor agonists. These compounds, along with their bioprecursors and pharmaceutically acceptable salts, are recognized for their therapeutic utilities. The processes for their preparation and the compositions containing these compounds are also detailed in his patents.

Career Highlights

Throughout his career, Brian R Holloway has worked with prominent companies such as Imperial Chemical Industries Limited and Zeneca Limited. His experience in these organizations has contributed to his expertise in the development of chemical compounds.

Collaborations

Holloway has collaborated with notable coworkers, including Ralph Howe and Balbir S Rao. Their combined efforts have further advanced the research and development of innovative chemical solutions.

Conclusion

Brian R Holloway's contributions to the field of chemical compounds highlight his role as a significant inventor. His patents and collaborations reflect his commitment to advancing therapeutic innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…